可能错误 过度解读 证据确定性: 低 初步 C-BAR-13

袖状胃切除术会导致自身免疫性疾病和纤维肌痛。

简而言之: 作为一般性陈述,这一说法很可能是错误的:没有发现类风湿关节炎增加,也没有证据表明手术会导致纤维肌痛;两项大型队列研究显示,袖状胃切除术与后来的炎症性肠病之间存在一种程度有限、未经证实的关联(绝对风险约为每年每 10,000 人 6 例)。
结论: 作为一般性说法很可能是错误的:没有发现类风湿关节炎增加,也没有证据表明手术会导致纤维肌痛;与炎症性肠病之间存在一种程度有限、未经证实的关联。

原始表述

التكميم يعمل فايبروميولجيا

按来源为原话. 译文由本项目提供;以阿拉伯语原文为准。

译文

袖状胃切除术会导致自身免疫性疾病和纤维肌痛。

出处

来源状态
视频转录文本(本人原话)
归属
Elawady (machine transcript)
视频
Dr Diaa Al Awady د ضياء العوضي is live! مقاومة الأنسولين ٢ (打开来源)
发布日期
2025年7月1日
时间戳
无(转录文本不含时间信息)
归属的不确定性
Archive transcript (YouTube CC or AI-generated); wording may contain transcription errors; no timestamps available.
所声称的机制

Undigested food, abdominal pressure and inflammation.

所声称的健康影响

Autoimmune disease, fibromyalgia.

涉及人群

Sleeve patients

Elawady 设定的地域限制

none found

来源版本存在差异

来源状态
视频转录文本(本人原话)
归属
Elawady (machine transcript)
视频
اتفرجوا عالبودكاست ده وقولولي رأيكوا عشان انزلكوا الحلقه التانيه منه (打开来源)
发布日期
2026年4月9日
时间戳
无(转录文本不含时间信息)
归属的不确定性
Archive transcript (YouTube CC or AI-generated); wording may contain transcription errors; no timestamps available.

科学评估

可能错误 – 现有证据倾向于不支持该说法,但尚无定论。

证据确定性: 低 – 进一步研究很可能大幅改变该评估。

1. 说法是什么?

Sleeve causes autoimmune disease and fibromyalgia.

2. 哪些内容可证实是正确的?

There is an observational signal for one immune-mediated disease: inflammatory bowel disease, especially ulcerative colitis, was diagnosed more often some years after sleeve gastrectomy in Swedish (I-BAR-138) and US (I-BAR-139) cohorts; absolute risk remains small (about 6 per 10,000 per year) and causation is not established.

3. 哪些内容是错误或夸大的?

The general claim that sleeve gastrectomy causes autoimmune diseases is not supported: no increase in rheumatoid arthritis was found over up to 29 years (I-INTC-09). For fibromyalgia, the available evidence points in the opposite direction: obesity is associated with worse symptoms and weight loss, including surgery, may improve them (I-INTC-11).

4. 哪些内容仍不明确?

Data specific to sleeve gastrectomy are scarce; the SOS surgery group had gastric banding (19%), vertical banded gastroplasty (68%) and gastric bypass (13%) and no sleeve gastrectomy at all, rheumatoid arthritis was not a predefined endpoint, and the authors state the study may be underpowered (I-INTC-09). The frequency of de novo IBD after surgery compared with the expected rate is unknown. Other autoimmune diseases were not studied in the sources found.

5. 哪些研究支持该说法?

I-INTC-10 (de novo IBD reported), I-BAR-138, I-BAR-139.

6. 哪些研究与该说法相矛盾?

I-INTC-09 and I-BAR-140 (no increase in RA); I-INTC-11 (weight loss including bariatric surgery may improve fibromyalgia).

7. 对德国和欧洲而言情况如何?

Most key data are European (Sweden SOS/SOReg, Finland SLEEVEPASS, Switzerland SM-BOSS). European and international society guidelines consider bariatric surgery for severe obesity with lifelong follow-up.

8. 关于埃及的已知情况是什么?

No Egypt-specific outcome data were identified in this review. Elawady states in a transcript that sleeve gastrectomy is very widely performed in Egypt ('مصر كلها بتعملها'); the procedure-specific risks (reflux, deficiencies) apply wherever it is performed, and follow-up quality (supplements, endoscopy, mental-health screening) determines part of the risk.

9. 合理的实际结论是什么?

根据现有证据,对自身免疫性疾病或纤维肌痛的恐惧并不是拒绝减重手术的理由;应与手术团队讨论已确立的风险(反流、营养素缺乏、需要随访)。

评估详情

证据确定性的依据

No increase in rheumatoid arthritis in SOS over a median of 21 years (HR 0.92, 0.59-1.46; I-INTC-09) or in an Israeli matched cohort (9 vs 9 cases; I-BAR-140). Fibromyalgia: no incidence data after surgery were found; weight loss may improve symptoms (I-INTC-11). Inflammatory bowel disease: two large cohorts report associations after sleeve (ulcerative colitis HR 1.8 vs general population, I-BAR-138; IBD aHR 2.28 after 3 years vs obese controls but 0.76 in the first 3 years, I-BAR-139), with small absolute risk and possible detection bias. Evidence is observational and largely not sleeve-specific, so certainty is low.

来源质量

Assertion without cited data.

地区可推广性

n/a

个体例外情况

n/a

说法的地域范围
普遍性(生物学/医学)
最近审核
2026年10月26日 初步

科学证据详解

过度解读 – 确有真实的发现,但该说法从中引申出的结论超出了数据所能支持的范围(例如把关联当作因果、把动物数据套用到人身上、把小效应说成大效应)。

研究问题: Does sleeve gastrectomy cause autoimmune diseases or fibromyalgia?

研究问题详解 (PECO)
人群
Adults after sleeve/bariatric surgery
干预或暴露
Sleeve gastrectomy / bariatric surgery
对照
Matched obese or general-population controls
地域范围
universal biology
结局指标
  • Incident autoimmune/immune-mediated diseases (RA, IBD)
  • Fibromyalgia

研究结果按作者报告呈现。我们的评估见下文。

哪些证据支持该说法?

哪些证据不支持该说法?

总体证据说明了什么?

基于上述研究的编辑评估——其本身并非研究结果。

哪种观点有更好的证据支持?

No evidence that sleeve causes autoimmune disease in general or fibromyalgia; a modest observational signal exists for inflammatory bowel disease (mainly ulcerative colitis) after sleeve, with very small absolute risk and unproven causation.

为什么有些研究权重更大

Two large cohorts for IBD give a signal; RA data consistently null; no fibromyalgia incidence data found.

因果关系是否已确立? 尚未确立 IBD signal could reflect detection bias or obesity-related confounding.

仍存在的不确定性

IBD mechanism; other autoimmune diseases unstudied.

合理的结论

Probably false as a general claim; IBD part is a real but small, unproven signal.

为什么研究结果看起来互相矛盾?

Early lower and late higher IBD risk (I-BAR-139) and procedure-specific patterns (I-BAR-138) suggest complex or artefactual associations.

这是否取决于国家?
一般生物学效应
Universal.
饮食习惯
Not applicable (surgical procedure, not a food).
食品原产地
Not applicable (surgical procedure, not a food).
污染物
Not applicable (surgical procedure, not a food).
本国生产条件
Not applicable.
法律规则
Not applicable.
实际监测数据
No Egyptian data found.

足以改变结论的地区差异没有可靠数据支持。

统计复核
  • Absolute rate difference – IBD 61.2 vs 44.4 per 100,000 per year: excess ~17 per 100,000 per year (crude). 已重新计算
总体证据的确定性(GRADE,简化版)
主要结局
Incident autoimmune/immune-mediated disease after sleeve
起始等级
低(观察性研究)
降级理由
  • inconsistency
  • imprecision
  • indirectness (fibromyalgia not studied)
结果
低

由单名审查者参照 GRADE 方法进行的简化评估;并非正式的 GRADE 专家组评估。GRADE 评价的是针对某一结局的整体证据,而非单项研究。

检索策略

本次审查的文献检索记录(检索式采用原数据库语法)。

数据库日期检索式检索目标命中数纳入数
Europe PMC2026年10月26日(TITLE:"autoimmune" OR TITLE:"fibromyalgia" OR TITLE:"inflammatory bowel disease" OR TITLE:"psoriasis" OR TITLE:"rheumatoid" OR TITLE:"lupus" OR TITLE:"multiple sclerosis") AND (TITLE:"bariatric" OR TITLE:"sleeve gastrectomy" OR TITLE:"metabolic surgery")双向104
PubMed2026年10月26日(fibromyalgia OR chronic widespread pain) AND (bariatric surgery OR sleeve gastrectomy OR gastric bypass)双向423
PubMed2026年10月26日(autoimmune disease*[tiab]) AND (bariatric surgery[tiab] OR sleeve gastrectomy[tiab]) AND (incidence OR risk) AND (cohort OR matched)双向0

待解决的问题

Fibromyalgia incidence after sleeve; IBD replication with endoscopy-controlled design.

核查深度如何?

6 项相关研究:1 项核查了全文(其中 1 项进行了结构化偏倚风险评估),5 项基于摘要核查,0 项仅核查了文献信息。 尚未进行由两名独立审查者完成的正式评估,也尚未进行独立的人类专家审核。

最近一次科学审核: 2026年10月26日

评定结论的变更历史
  1. 2026年10月25日 · 第 1 阶段 · 初始评估: 可能错误 (低)
  2. 2026年10月26日 · 第 4 阶段(系统证据审查) · 在扩展证据后重新审查;评定结论不变: 可能错误 (低)
    Verdict (POTENTIALLY_FALSE) and certainty (low) unchanged. New cohorts strengthen the IBD signal somewhat and confirm no RA increase; review text updated accordingly.
    新来源: I-BAR-140 I-BAR-138 I-BAR-139

通俗解释

Elawady 说,袖状胃切除术会导致自身免疫性疾病和纤维肌痛。一项长期的瑞典研究发现,在约 21 年中,减重手术并未增加类风湿关节炎。关于纤维肌痛,早期研究提示,减重(包括通过手术减重)可能会减轻症状。一些报告描述了减重手术后新发的炎症性肠病,但尚不清楚这种情况有多常见,也不清楚是否由手术引起。

与该说法相关的研究

支持该说法的研究 (0)

该组中没有研究。

与该说法相矛盾或限制该说法的研究 (3)

  • Weight-loss surgery and rheumatoid arthritis

    Maglio C et al.. Rheumatology (Oxford) 2020 · PMID 31321442 · DOI 10.1093/rheumatology/kez275
    队列研究独立交叉核查全文,含结构化偏倚风险评估★ 关键研究

    Over a median of 21 years, people who had weight-loss surgery did not develop rheumatoid arthritis more often than matched controls.

    No increase in rheumatoid arthritis after bariatric surgery (HR 0.92).

    该研究是否支持这一具体说法? 否 · 方法学质量: 中 · 证据确定性:见该说法的总体评估

    原始文献 · 科学细节

    研究通俗解读
    研究人员想了解什么?

    Test bariatric surgery and RA incidence

    研究是如何开展的?

    Matched cohort

    研究了多少人、动物或样本?

    4036 adults with obesity

    实际发现了什么?

    No association

    观察到的效应有多大?

    HR 0.92 (0.59-1.46)

    研究结果对日常生活意味着什么?

    Surgery did not raise the risk of rheumatoid arthritis.

    该研究有哪些局限?

    Few cases; older surgery types; not randomised

    它对 Elawady 的具体说法说明了什么?

    Contradicts 'surgery causes autoimmune disease' for RA

    研究结果是否适用于德国和欧洲?

    High

    从该研究中明确不能得出什么结论?

    Effects of sleeve gastrectomy specifically; other autoimmune diseases

    科学细节 →

  • Fibromyalgia and obesity

    D'Onghia M et al.. Semin Arthritis Rheum 2021 · PMID 33676126 · DOI 10.1016/j.semarthrit.2021.02.007
    Meta分析独立交叉核查已核查摘要

    About one in three people with fibromyalgia has obesity; early studies suggest weight loss, including surgery, may ease symptoms.

    Weight loss (incl. surgery) preliminarily improves FM symptoms.

    该研究是否支持这一具体说法? 否 · 方法学质量: 中 · 证据确定性:见该说法的总体评估

    原始文献 · 科学细节

    研究通俗解读
    研究人员想了解什么?

    Review FM and obesity

    研究是如何开展的?

    Systematic review and meta-analysis

    研究了多少人、动物或样本?

    41 studies

    实际发现了什么?

    Obesity common in FM; weight loss may help

    观察到的效应有多大?

    Obesity prevalence 35.7% (31.8-39.9%)

    研究结果对日常生活意味着什么?

    Losing weight may help fibromyalgia.

    该研究有哪些局限?

    High risk of bias; few weight-loss studies

    它对 Elawady 的具体说法说明了什么?

    Does not support 'surgery causes fibromyalgia'

    研究结果是否适用于德国和欧洲?

    High

    从该研究中明确不能得出什么结论?

    Proof of benefit or harm from sleeve gastrectomy

    科学细节 →

  • Israeli study: rheumatoid arthritis after surgery

    Jeries et al.. Rheumatol Adv Pract 2026 · PMID 41908723 · DOI 10.1093/rap/rkag025
    队列研究独立交叉核查已核查摘要

    Rheumatoid arthritis appeared equally rarely in operated and non-operated people (9 cases each).

    RA incidence identical (9 vs 9) after surgery and in controls.

    该研究是否支持这一具体说法? 否 · 方法学质量: 低 · 证据确定性:见该说法的总体评估

    原始文献 · 科学细节

    研究通俗解读
    研究人员想了解什么?

    RA after surgery

    研究是如何开展的?

    Matched cohort

    研究了多少人、动物或样本?

    19,166

    实际发现了什么?

    9 vs 9 cases

    观察到的效应有多大?

    No difference

    研究结果对日常生活意味着什么?

    No sign of more arthritis

    该研究有哪些局限?

    Very few cases

    它对 Elawady 的具体说法说明了什么?

    Contradicts the RA part

    研究结果是否适用于德国和欧洲?

    Plausible

    从该研究中明确不能得出什么结论?

    Small effects

    科学细节 →

结果不一或不明确的研究 (3)

  • Bowel inflammation after weight-loss surgery

    Mian A et al.. Surgeon 2023 · PMID 35660070 · DOI 10.1016/j.surge.2022.04.008
    系统综述独立交叉核查已核查摘要

    Some studies report new inflammatory bowel disease after weight-loss surgery, but how often and whether surgery causes it is unknown.

    De novo IBD reported after bariatric surgery; causation and rate unknown.

    该研究是否支持这一具体说法? 部分支持 · 方法学质量: 低 · 证据确定性:见该说法的总体评估

    原始文献 · 科学细节

    研究通俗解读
    研究人员想了解什么?

    Review bariatric surgery and IBD

    研究是如何开展的?

    Systematic review of 22 studies

    研究了多少人、动物或样本?

    Patients with/without IBD

    实际发现了什么?

    Safe in IBD; de novo IBD reported

    观察到的效应有多大?

    not reported

    研究结果对日常生活意味着什么?

    A possible rare link exists but is unproven.

    该研究有哪些局限?

    Weak study types; no rates

    它对 Elawady 的具体说法说明了什么?

    Weak partial support

    研究结果是否适用于德国和欧洲?

    High

    从该研究中明确不能得出什么结论?

    Causation

    科学细节 →

  • Swedish study: bowel inflammation after obesity surgery

    Kiasat et al.. Surg Obes Relat Dis 2022 · PMID 35012883 · DOI 10.1016/j.soard.2021.12.014
    队列研究独立交叉核查已核查摘要★ 关键研究

    Ulcerative colitis was diagnosed more often after sleeve (and Crohn disease after bypass) than in the general population.

    SG associated with UC (HR 1.8) vs general population; confounded by obesity.

    该研究是否支持这一具体说法? 部分支持 · 方法学质量: 中 · 证据确定性:见该说法的总体评估

    原始文献 · 科学细节

    研究通俗解读
    研究人员想了解什么?

    IBD after surgery

    研究是如何开展的?

    Register cohort

    研究了多少人、动物或样本?

    698,718

    实际发现了什么?

    SG: UC HR 1.8

    观察到的效应有多大?

    HR 1.8

    研究结果对日常生活意味着什么?

    A possible, small link with bowel inflammation

    该研究有哪些局限?

    Controls not obese

    它对 Elawady 的具体说法说明了什么?

    Partly supports immune-disease claim (IBD only)

    研究结果是否适用于德国和欧洲?

    Directly European

    从该研究中明确不能得出什么结论?

    Causation

    科学细节 →

  • US study: bowel inflammation after surgery

    Pusateri et al.. Obes Surg 2026 · PMID 42082785 · DOI 10.1007/s11695-026-08714-1
    队列研究独立交叉核查已核查摘要

    Bowel inflammation was less common in the first 3 years after surgery but more common afterwards, especially after sleeve; it remained rare.

    Late IBD aHR 2.28 after MBS (esp. VSG) vs obese controls; early aHR 0.76.

    该研究是否支持这一具体说法? 部分支持 · 方法学质量: 中 · 证据确定性:见该说法的总体评估

    原始文献 · 科学细节

    研究通俗解读
    研究人员想了解什么?

    IBD timing after MBS

    研究是如何开展的?

    Claims cohort

    研究了多少人、动物或样本?

    477,687

    实际发现了什么?

    Late aHR 2.28

    观察到的效应有多大?

    61 vs 44 per 100,000/y

    研究结果对日常生活意味着什么?

    Small possible risk

    该研究有哪些局限?

    Claims data

    它对 Elawady 的具体说法说明了什么?

    Partly supports IBD part

    研究结果是否适用于德国和欧洲?

    US

    从该研究中明确不能得出什么结论?

    Causation

    科学细节 →

地区背景

德国 / 欧盟

Most key data are European (Sweden SOS/SOReg, Finland SLEEVEPASS, Switzerland SM-BOSS). European and international society guidelines consider bariatric surgery for severe obesity with lifelong follow-up.

埃及

No Egypt-specific outcome data were identified in this review. Elawady states in a transcript that sleeve gastrectomy is very widely performed in Egypt ('مصر كلها بتعملها'); the procedure-specific risks (reflux, deficiencies) apply wherever it is performed, and follow-up quality (supplements, endoscopy, mental-health screening) determines part of the risk.

在我的国家适用什么?

一般科学评估

可能错误 作为一般性说法很可能是错误的:没有发现类风湿关节炎增加,也没有证据表明手术会导致纤维肌痛;与炎症性肠病之间存在一种程度有限、未经证实的关联。

该说法涉及生物学或医学关系。上述科学评估不论在哪个国家都适用;各国食品数据不会改变这一评估。

参考文献

  1. Bariatric surgery and the incidence of rheumatoid arthritis - a Swedish Obese Subjects study.. Maglio C et al.. Rheumatology (Oxford) 2020 · PMID 31321442 · DOI 10.1093/rheumatology/kez275
  2. Fibromyalgia and obesity: A comprehensive systematic review and meta-analysis.. D'Onghia M et al.. Semin Arthritis Rheum 2021 · PMID 33676126 · DOI 10.1016/j.semarthrit.2021.02.007
  3. The association between bariatric surgery and incident rheumatoid arthritis.. Jeries et al.. Rheumatol Adv Pract 2026 · PMID 41908723 · DOI 10.1093/rap/rkag025
  4. Systematic review: Outcomes of bariatric surgery in patients with inflammatory bowel disease and de-novo IBD development after bariatric surgery.. Mian A et al.. Surgeon 2023 · PMID 35660070 · DOI 10.1016/j.surge.2022.04.008
  5. The risk of inflammatory bowel disease after bariatric surgery.. Kiasat et al.. Surg Obes Relat Dis 2022 · PMID 35012883 · DOI 10.1016/j.soard.2021.12.014
  6. The Impact of Metabolic Bariatric Surgery on Inflammatory Bowel Disease Risk and Outcomes in Adults With Obesity: a Propensity-matched, Nationwide, Analysis.. Pusateri et al.. Obes Surg 2026 · PMID 42082785 · DOI 10.1007/s11695-026-08714-1

← 返回概览